Authors: T M Curtis R Hamilton PH Yong C M McVicar A Berner R Pringle K Uchida R Nagai S Brockbank A W Stitt
Publish Date: 2010/11/30
Volume: 54, Issue: 3, Pages: 690-698
Abstract
The impact of AGEs and advanced lipoxidation endproducts ALEs on neuronal and Müller glial dysfunction in the diabetic retina is not well understood We therefore sought to identify dysfunction of the retinal Müller glia during diabetes and to determine whether inhibition of AGEs/ALEs can prevent itSprague–Dawley rats were divided into three groups 1 nondiabetic 2 untreated streptozotocininduced diabetic and 3 diabetic treated with the AGE/ALE inhibitor pyridoxamine for the duration of diabetes Rats were killed and their retinas were evaluated for neuroglial pathologyAGEs and ALEs accumulated at higher levels in diabetic retinas than in controls p 0001 AGE/ALE immunoreactivity was significantly diminished by pyridoxamine treatment of diabetic rats Diabetes was also associated with the upregulation of the oxidative stress marker haemoxygenase1 and the induction of glial fibrillary acidic protein production in Müller glia p 0001 Pyridoxamine treatment of diabetic rats had a significant beneficial effect on both variables p 0001 Diabetes also significantly altered the normal localisation of the potassium inwardly rectifying channel Kir41 and the water channel aquaporin 4 to the Müller glia endfeet interacting with retinal capillaries These abnormalities were prevented by pyridoxamine treatment
Keywords: